Soufflé Therapeutics logo

Soufflé Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
13
Total Funding
$330.6M
Investors
13 investors across all rounds
AV
AbbVie Ventures
A
Amgen
AV
ARCH Venture Partners
OTHER
BV
Bessemer Venture Partners
OTHER
BC
Breyer Capital
OTHER

+8 more investors

Sign in to view all

Explore More Data
Detailed analysis for Soufflé Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Soufflé Therapeutics Leadership & Investors

Soufflé Therapeutics is led by a team of experienced leaders. The company has attracted investment from 13 institutional and strategic investors.

Who Has Invested in Soufflé Therapeutics?

Soufflé Therapeutics has raised $330.6M from 13 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Soufflé Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.